These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 10817618)

  • 1. Neuroprotective potency of kynurenic acid against excitotoxicity.
    Urenjak J; Obrenovitch TP
    Neuroreport; 2000 Apr; 11(6):1341-4. PubMed ID: 10817618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kynurenine 3-hydroxylase inhibition in rats: effects on extracellular kynurenic acid concentration and N-methyl-D-aspartate-induced depolarisation in the striatum.
    Urenjak J; Obrenovitch TP
    J Neurochem; 2000 Dec; 75(6):2427-33. PubMed ID: 11080194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo assessment of kynurenate neuroprotective potency and quinolinate excitotoxicity.
    Obrenovitch TP; Urenjak J
    Amino Acids; 2000; 19(1):299-309. PubMed ID: 11026501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kynurenic acid analogues with improved affinity and selectivity for the glycine site on the N-methyl-D-aspartate receptor from rat brain.
    Foster AC; Kemp JA; Leeson PD; Grimwood S; Donald AE; Marshall GR; Priestley T; Smith JD; Carling RW
    Mol Pharmacol; 1992 May; 41(5):914-22. PubMed ID: 1375317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kynurenic acid attenuates NMDA-induced pial arteriolar dilation in newborn pigs.
    Bari F; Nagy K; Guidetti P; Schwarcz R; Busija DW; Domoki F
    Brain Res; 2006 Jan; 1069(1):39-46. PubMed ID: 16388784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimation of the relative potency of two glycine antagonists on NMDA-induced depolarizations in BRSC and ARCS.
    Corsi M; Bettelini L; Fina P; Trist DG
    Ann N Y Acad Sci; 1997 May; 812():187-8. PubMed ID: 9186738
    [No Abstract]   [Full Text] [Related]  

  • 7. Differential action of NMDA antagonists on cholinergic neurotoxicity produced by N-methyl-D-aspartate and quinolinic acid.
    Pawley AC; Flesher S; Boegman RJ; Beninger RJ; Jhamandas KH
    Br J Pharmacol; 1996 Mar; 117(6):1059-64. PubMed ID: 8882597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In situ produced 7-chlorokynurenate provides protection against quinolinate- and malonate-induced neurotoxicity in the rat striatum.
    Guidetti P; Wu HQ; Schwarcz R
    Exp Neurol; 2000 May; 163(1):123-30. PubMed ID: 10785450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrastriatal Quinolinic Acid Administration Impairs Redox Homeostasis and Induces Inflammatory Changes: Prevention by Kynurenic Acid.
    Ferreira FS; Schmitz F; Marques EP; Siebert C; Wyse ATS
    Neurotox Res; 2020 Jun; 38(1):50-58. PubMed ID: 32219734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual effect of DL-homocysteine and S-adenosylhomocysteine on brain synthesis of the glutamate receptor antagonist, kynurenic acid.
    Luchowska E; Luchowski P; Paczek R; Ziembowicz A; Kocki T; Turski WA; Wielosz M; Lazarewicz J; Urbanska EM
    J Neurosci Res; 2005 Feb; 79(3):375-82. PubMed ID: 15605380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enzyme-catalyzed production of the neuroprotective NMDA receptor antagonist 7-chlorokynurenic acid in the rat brain in vivo.
    Wu HQ; Salituro FG; Schwarcz R
    Eur J Pharmacol; 1997 Jan; 319(1):13-20. PubMed ID: 9030892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of five glycine site antagonists on NMDA receptor desensitisation.
    Molnár P; Erdõ SL
    Eur J Pharmacol; 1996 Sep; 311(2-3):311-4. PubMed ID: 8891614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurodegeneration induced by reversed microdialysis of NMDA; a quantitative model for excitotoxicity in vivo.
    Vanický I; Marsala M; Yaksh TL
    Brain Res; 1998 Apr; 789(2):347-50. PubMed ID: 9573401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of excitatory amino acid release by N-methyl-D-aspartate receptors in rat striatum: in vivo microdialysis studies.
    Bustos G; Abarca J; Forray MI; Gysling K; Bradberry CW; Roth RH
    Brain Res; 1992 Jul; 585(1-2):105-15. PubMed ID: 1355000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Excitatory amino acid-induced excitation of dopamine-containing neurons in the rat substantia nigra: modulation by kynurenic acid.
    Wu HQ; Schwarcz R; Shepard PD
    Synapse; 1994 Mar; 16(3):219-30. PubMed ID: 7515199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kynurenate and 7-chlorokynurenate formation in chronically epileptic rats.
    Wu HQ; Rassoulpour A; Goodman JH; Scharfman HE; Bertram EH; Schwarcz R
    Epilepsia; 2005 Jul; 46(7):1010-6. PubMed ID: 16026552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kynurenic Acid Restores Nrf2 Levels and Prevents Quinolinic Acid-Induced Toxicity in Rat Striatal Slices.
    Ferreira FS; Biasibetti-Brendler H; Pierozan P; Schmitz F; Bertó CG; Prezzi CA; Manfredini V; Wyse ATS
    Mol Neurobiol; 2018 Nov; 55(11):8538-8549. PubMed ID: 29564809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kynurenic acid leads, dopamine follows: a new case of volume transmission in the brain?
    Wu HQ; Rassoulpour A; Schwarcz R
    J Neural Transm (Vienna); 2007 Jan; 114(1):33-41. PubMed ID: 16932989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kynurenic acid, by targeting α7 nicotinic acetylcholine receptors, modulates extracellular GABA levels in the rat striatum in vivo.
    Beggiato S; Antonelli T; Tomasini MC; Tanganelli S; Fuxe K; Schwarcz R; Ferraro L
    Eur J Neurosci; 2013 May; 37(9):1470-7. PubMed ID: 23442092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance to kynurenic acid of the NMDA receptor-dependent toxicity of 3-nitropropionic acid and cyanide in cerebellar granule neurons.
    Fatokun AA; Smith RA; Stone TW
    Brain Res; 2008 Jun; 1215():200-7. PubMed ID: 18486115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.